Texas Capital Bancshares is a Dallas-based regional bank, and TCBIO is its 5.75% fixed-rate non-cumulative perpetual preferred, represented by depositary shares that each carry a fractional interest in the underlying preferred. The senior claim sits ahead of common equity, so the security's appeal rests on the bank's ability to keep paying its dividend rather than on earnings growth. The reported 8.6% revenue growth and 10.2% ROE point to a bank earning a reasonable return on its equity base, while the 36.7% operating margin and a trailing P/E of 4.6 suggest the market is pricing in meaningful skepticism about that earnings stream. The data available here does not include credit quality, capital ratios or deposit trends, so the first diligence step is to pull the bank's CET1 ratio and its recent provisions to judge whether the preferred coupon is well covered. Given the 59/100 score and no index membership, this name merits a deeper look only if those capital and credit figures hold up.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 20 Oct 2026, 16:04 CEST | Rating | Undervalued | first publication | $18.28 |
| 11 Oct 2026, 00:00 CEST | Fair value | $37.97 | $18.32 | $18.28 |
| 11 Oct 2026, 00:00 CEST | ACCE price target | $19.00 | first publication | $18.28 |
| 5 Oct 2026, 00:00 CEST | Fair value | $18.32 | $17.95 | $18.90 |
| 30 Sept 2026, 00:00 CEST | Fair value | $17.95 | $29.49 | $18.35 |
| 28 Sept 2026, 00:00 CEST | Fair value | $29.49 | $19.13 | $18.64 |
| 26 Sept 2026, 00:00 CEST | Fair value | $19.13 | $19.93 | $18.86 |
| 14 Sept 2026, 00:00 CEST | Fair value | $19.93 | $20.70 | $19.71 |
| 9 Sept 2026, 00:00 CEST | Fair value | $20.70 | $21.03 | $19.90 |
| 6 Sept 2026, 00:00 CEST | Fair value | $21.03 | $34.90 | $19.90 |
Answered from Texas Capital Bancshares Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| TCBIO Texas Capital Bancshares Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B | $18.28 | $38 | 52% below | 4.6x | 10.2% | 85 | 59 |
| BBAR.BA BBVA Banco Frances SA | ARS 7240.00 | - | - | 11.0x | 8.1% | 71 | 68 |
| BMA.BA Banco Macro SA B | ARS 10870.00 | - | - | 15.4x | 7.1% | 79 | 57 |
| BOGOTA.CL Banco de Bogota | COP 38240.00 | - | - | 9.0x | 9.2% | 61 | 49 |
| PFDAVVNDA.CL Davivienda Group preferred | COP 28740.00 | - | - | 8.2x | 10.3% | 53 | 82 |
| ITAUCL.SN Banco Itau Chile | CLP 22500.00 | - | - | 12.3x | 9.4% | 81 | 71 |
| PFAVAL.CL Grupo Aval preferred | COP 780.00 | - | - | 10.8x | 10.0% | 58 | 71 |
Where TCBIO ranks against its sector peers on each metric.